Advanced Research Investment Solutions’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed -$2K 27
2022
Q3
$2K Hold
8
﹤0.01% 150
2022
Q2
$2K Hold
8
﹤0.01% 122
2022
Q1
$2K Hold
8
﹤0.01% 181
2021
Q4
$1K Hold
8
﹤0.01% 186
2021
Q3
$1.7K Hold
8
﹤0.01% 134
2021
Q2
$2K Hold
8
﹤0.01% 70
2021
Q1
$2K Hold
8
﹤0.01% 63
2020
Q4
$2K Buy
+8
New +$1.84K ﹤0.01% 58

Other funds holding AMGN

Advanced Research Investment Solutions's AMGN Position: Q4 2022 in Review

Advanced Research Investment Solutions sold out of Amgen (AMGN) in Q4 2022, closing a stake of 8 shares — an estimated $2K sold.

Advanced Research Investment Solutions first reported a position in AMGN in Q4 2020 and held it in 8 quarters. The position peaked at $2K in Q3 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Advanced Research Investment Solutions reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Advanced Research Investment Solutions sold 8 Amgen shares in Q4 2022, an estimated $2K.
  • Advanced Research Investment Solutions first reported a position in Amgen in Q4 2020 and held it in 8 quarters.
  • Advanced Research Investment Solutions's Amgen position peaked at $2K in Q3 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Advanced Research Investment Solutions's 13F filing for Q4 2022, filed 10 Feb 2023.